![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.45 | 4.30 | 4.60 | 4.45 | 4.45 | 4.45 | 343,084 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.60 | 23.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2023 15:18 | Investingisatrickyga 0 0 0 So everyone, filter out NeutralPOV, ravenna23, erinvale1 and any other like posters so that you may better focus on the reality of what IS happening, rather than individuals misinforming you and trashing the Company and posters here. I have and I never see their posts. -------------------- Hmm. Ravenna and Erinvale supply valid critique, albeit with a certain amount of long standing grievance. Afaic, this company has failed every financial prediction that you and Atty between you have made in the time that I've been reading these boards, notwithstanding that you do good research on the tech and market opportunities. The problem is the gap between the quantities being sold and the abstraction of total potential. To put it differently, I'd rather have a corner shop with actual fcf, selling toilet paper at x margin of profit, than a pumpkin carriage promising to sell the elixir of life, but with an endless record of fundraisings. If my share of the elixir is reduced more quickly than the promised extension of my life-span, I am not a happy fairy! I think this is problem and no amount of magic dust around 'total market size' will dispel the doubt that this is in effect run as a life style company. So to clarify: when, according to your analysis, will EDEN be covering all running costs (6m?) and actually making a profit? That at least will give us a metric of expectation to return to. Up to now it has survived on periodic spikes of the share price - the last one rather suspiciously aligned with an article promoting the share- in order to raise just enough to stagger forward for the next couple of years. | ![]() brucie5 | |
06/12/2023 15:07 | From the hxxps://onlinexperie @21:20 the insecticide is potentially worth $35-40 million per annum for Eden @16-16:25 Ecovelex, $35-40 million per annum for Eden The Company with these 2 products alone is anticipating around $70-$80 million dollars per annum. If, for example, Ecovelex performed at this level for 10 years, that's $700-800 million. Pick another timeframe to get an answer that suits you. For sure, today's market cap of £22.4 million looks quite ridiculous on this basis. Eden could over time, hundreds of millions of $ for these 2 products based on the length of regulatory approval. Even if Eden Research is not the immediate recipient of this potential income, I am sure they would consider similar numbers in any discussions they might have in the future with any potential interested party. Having done the hard miles, it is not going to go cheaply, is it! So everyone, filter out NeutralPOV, ravenna23, erinvale1 and any other like posters so that you may better focus on the reality of what IS happening, rather than individuals misinforming you and trashing the Company and posters here. I have and I never see their posts. | ![]() investingisatrickygame | |
06/12/2023 14:14 | To be fair to her, Neuts is getting closer every day. | ![]() timbo_slice | |
06/12/2023 13:59 | Any idea of this timeline for zero pence. I think you have been banging on about it since March 2021?! | ![]() kittybiscuits | |
06/12/2023 12:40 | Renewed target SP EDEN RESEARCH plc ZERO PENCE - - - 0.0000p | ![]() neutralpov | |
06/12/2023 12:28 | Rattled Lube. | ![]() supersonico | |
06/12/2023 12:04 | Neuts,Do you ever engage your brain? Surely you'd want me to find a busy track, not a deserted one!!!! Mango | ![]() timbo_slice | |
06/12/2023 11:18 | 100% not Vicarious Liability.Why would I exit at 12 pence (plus you could not actually sell at that price), that's a loss for me...... I'm here for big bucks or bust ... if EDEN goes to zero so be it. | ![]() timbo_slice | |
06/12/2023 11:10 | Anyway, you chose not to edit at 12p. | ![]() ravenna23 | |
06/12/2023 11:10 | It is difficult to see how Eden can survive: negligible sales and the Directors continuing to award themselves vast salaries - and even bonuses - for lacklustre performance. What is surprising is that corporate investors - if any remain - do not take action to replace the board and continue to support this company. | ![]() erinvale1 | |
06/12/2023 11:08 | Depends if individuals posting here are employed by interested parties. | ![]() ravenna23 | |
06/12/2023 11:04 | Vicarious liability does not apply here. Rav, whilst the sales of EDEN are not zero, they are disappointing over a longer timescale. I still *HOPE* that EDEN are in the right place at the right time otherwise ............. | ![]() timbo_slice | |
06/12/2023 11:01 | Tell your employer that. | ![]() ravenna23 | |
06/12/2023 11:00 | Lube Law definitions ... always funny. HAHA | ![]() supersonico | |
06/12/2023 10:49 | Vicarious liability | ![]() ravenna23 | |
06/12/2023 10:49 | By saying Eden is Ok you have vicarious liability. | ![]() ravenna23 | |
06/12/2023 10:47 | Best Guess has a wild imagination it would seem. | ![]() supersonico | |
06/12/2023 10:42 | And who is advising others to invest? | ![]() kittybiscuits | |
06/12/2023 10:32 | Best Guess, Your logic looks more like a sacrament than any attempt at reasonable debate. | ![]() supersonico | |
06/12/2023 10:24 | Eden sales close to zero. Despite raising large amounts of cash share price in decline. Draw your own conclusions, but do not encourage others to invest. | ![]() ravenna23 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions